Stock Scorecard
Stock Summary for Scholar Rock Holding Corp (SRRK) - $35.19 as of 10/3/2025 3:26:23 PM EST
Total Score
8 out of 30
Safety Score
46 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for SRRK
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for SRRK
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for SRRK
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for SRRK
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for SRRK (46 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 7 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for SRRK
Financial Details for SRRK
Company Overview |
|
|---|---|
| Ticker | SRRK |
| Company Name | Scholar Rock Holding Corp |
| Country | USA |
| Description | Scholar Rock Holding Corporation is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to the development of innovative therapies targeting serious diseases influenced by protein growth factor signaling. The company employs a unique approach to unlock the therapeutic potential of the TGF-beta superfamily, with a robust pipeline focused on conditions such as muscular dystrophy and cancer. Scholar Rock aims to transform patient outcomes by advancing its specialized treatments through rigorous scientific research and strategic collaborations. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/17/2025 |
Stock Price History |
|
| Last Day Price | 35.19 |
| Price 4 Years Ago | 24.84 |
| Last Day Price Updated | 10/3/2025 3:26:23 PM EST |
| Last Day Volume | 2,095,563 |
| Average Daily Volume | 2,482,279 |
| 52-Week High | 46.98 |
| 52-Week Low | 22.71 |
| Last Price to 52 Week Low | 54.95% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 21.94 |
| Sector PE | 41.81 |
| 5-Year Average PE | -12.09 |
| Free Cash Flow Ratio | 22.13 |
| Industry Free Cash Flow Ratio | 14.52 |
| Sector Free Cash Flow Ratio | 30.43 |
| Current Ratio Most Recent Quarter | 6.33 |
| Total Cash Per Share | 1.59 |
| Book Value Per Share Most Recent Quarter | 2.43 |
| Price to Book Ratio | 14.50 |
| Industry Price to Book Ratio | 29.60 |
| Sector Price to Book Ratio | 32.30 |
| Price to Sales Ratio Twelve Trailing Months | 13.14 |
| Industry Price to Sales Ratio Twelve Trailing Months | 43.64 |
| Sector Price to Sales Ratio Twelve Trailing Months | 20.26 |
| Analyst Buy Ratings | 8 |
| Analyst Strong Buy Ratings | 4 |
Share Statistics |
|
| Total Shares Outstanding | 96,127,000 |
| Market Capitalization | 3,382,709,130 |
| Institutional Ownership | 118.28% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -48.56% |
| Reported EPS 12 Trailing Months | -2.92 |
| Reported EPS Past Year | -1.65 |
| Reported EPS Prior Year | -2.46 |
| Net Income Twelve Trailing Months | -315,687,000 |
| Net Income Past Year | -246,294,000 |
| Net Income Prior Year | -165,789,000 |
| Quarterly Revenue Growth YOY | -100.00% |
| 5-Year Revenue Growth | -100.00% |
| Operating Margin Twelve Trailing Months | 0.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 152,925,000 |
| Total Cash Past Year | 177,878,000 |
| Total Cash Prior Year | 101,855,000 |
| Net Cash Position Most Recent Quarter | 103,169,000 |
| Net Cash Position Past Year | 127,732,000 |
| Long Term Debt Past Year | 50,146,000 |
| Long Term Debt Prior Year | 48,684,000 |
| Total Debt Most Recent Quarter | 49,756,000 |
| Equity to Debt Ratio Past Year | 0.88 |
| Equity to Debt Ratio Most Recent Quarter | 0.82 |
| Total Stockholder Equity Past Year | 368,634,000 |
| Total Stockholder Equity Prior Year | 225,218,000 |
| Total Stockholder Equity Most Recent Quarter | 233,293,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -258,123,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -2.69 |
| Free Cash Flow Past Year | -201,047,000 |
| Free Cash Flow Prior Year | -145,297,000 |
Options |
|
| Put/Call Ratio | 0.01 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.43 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 10/4/2025 9:55:46 AM EST |